Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibault Verjat

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biotechniques|October 9, 2004
Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profilingThibault Verjat, Elisabeth Cerrato, Marcel Jacobs, et al.
BMC Cancer|September 2, 2006
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancerPhilippe Leissner, Thibault Verjat, Thomas Bachelot, et al.
American Journal of Clinical Pathology|August 22, 2007
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expressionPierre-Jean Lamy, Thibault Verjat, Anne-Claire Servanton, et al.
Clinical Chemistry and Laboratory Medicine|December 27, 2005
NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancerPierre-Jean Lamy, Thibault Verjat, Malick Paye, et al.
Molecular Cancer Therapeutics|October 17, 2006
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancerLissandra Dal Lago, Virginie Durbecq, Christine Desmedt, et al.
Journal of Virology|July 18, 2008
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancerRafael Contreras-Galindo, Mark H Kaplan, Philippe Leissner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biotechniques|October 9, 2004
Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profilingThibault Verjat, Elisabeth Cerrato, Marcel Jacobs, et al.
BMC Cancer|September 2, 2006
Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancerPhilippe Leissner, Thibault Verjat, Thomas Bachelot, et al.
American Journal of Clinical Pathology|August 22, 2007
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expressionPierre-Jean Lamy, Thibault Verjat, Anne-Claire Servanton, et al.
Clinical Chemistry and Laboratory Medicine|December 27, 2005
NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancerPierre-Jean Lamy, Thibault Verjat, Malick Paye, et al.
Molecular Cancer Therapeutics|October 17, 2006
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancerLissandra Dal Lago, Virginie Durbecq, Christine Desmedt, et al.
Journal of Virology|July 18, 2008
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancerRafael Contreras-Galindo, Mark H Kaplan, Philippe Leissner, et al.
Pageof 1